Laphroaig (pronounced “la-froyg”) has been described as tasting of bandages, seaweed, and hospital corridors. Its admirers consider this a compliment. There is no whisky more immediately recognisable on the nose, and none that more completely divides opinion — which, counterintuitively, is part of its investment strength.
The Distillery
Founded in 1815 on Islay’s southern coast, Laphroaig uses its own floor maltings — one of the few distilleries still to do so — where Islay peat is burned beneath the barley. This peat, cut from bogs just a few hundred metres from the distillery, carries the island’s specific coastal, medicinal character. It cannot be replicated elsewhere.
Laphroaig is a Royal Warrant holder — the only whisky to carry the endorsement of King Charles III, a preference he held as Prince of Wales for decades. This association with Royal endorsement has given Laphroaig a cultural positioning unusual for such an idiosyncratic whisky.
The Investment Profile
Laphroaig’s “Friends of Laphroaig” community — members are entitled to a lifetime lease on a square foot of Islay peat bog — creates unusual collector loyalty. Limited releases tied to the programme, and annual editions like the Cairdeas (friendship) range, consistently outperform their release price at auction.
Older Laphroaig expressions from the 1960s and 1970s, bottled by Gordon & MacPhail and Cadenhead’s, represent some of the finest old Islay whisky accessible on the secondary market. Birchwood Stanhope currently holds Laphroaig X5 hogsheads from 2010 and 2011 fills — available for enquiry through The Cellar.